Literature DB >> 16941681

FIB-4: a simple, inexpensive and accurate marker of fibrosis in HCV-infected patients.

Anaïs Vallet-Pichard, Vincent Mallet, Stanislas Pol.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16941681     DOI： 10.1002/hep.21334

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  33 in total

1.  Advanced liver fibrosis and care continuum in emergency department patients with chronic hepatitis C.

Authors:  Yu-Hsiang Hsieh; Danielle Signer; Anuj V Patel; Valentina Viertel; Mustapha Saheed; Risha Irvin; Mark S Sulkowski; David L Thomas; Richard E Rothman
Journal:  Am J Emerg Med       Date:  2018-08-29       Impact factor: 2.469

2.  Relationship between alcohol use categories and noninvasive markers of advanced hepatic fibrosis in HIV-infected, chronic hepatitis C virus-infected, and uninfected patients.

Authors:  Joseph K Lim; Janet P Tate; Shawn L Fultz; Joseph L Goulet; Joseph Conigliaro; Kendall J Bryant; Adam J Gordon; Cynthia Gibert; David Rimland; Matthew Bidwell Goetz; Marina B Klein; David A Fiellin; Amy C Justice; Vincent Lo Re
Journal:  Clin Infect Dis       Date:  2014-02-25       Impact factor: 9.079

Review 3.  Applying Non-Invasive Fibrosis Measurements in NAFLD/NASH: Progress to Date.

Authors:  Somaya Albhaisi; Arun J Sanyal
Journal:  Pharmaceut Med       Date:  2019-12

4.  Comparison of elastography, serum marker scores, and histology for the assessment of liver fibrosis in hepatitis B virus (HBV)-infected patients in Burkina Faso.

Authors:  Philippe Bonnard; Roger Sombié; Francois-Xavier Lescure; Alain Bougouma; Jean Baptiste Guiard-Schmid; Thierry Poynard; Paul Calès; Chantal Housset; Patrice Callard; Catherine Le Pendeven; Joseph Drabo; Fabrice Carrat; Gilles Pialoux
Journal:  Am J Trop Med Hyg       Date:  2010-03       Impact factor: 2.345

Review 5.  Biomarkers in nonalcoholic fatty liver disease-the emperor has no clothes?

Authors:  Madhusudana Girija Sanal
Journal:  World J Gastroenterol       Date:  2015-03-21       Impact factor: 5.742

6.  External validation of P2/MS and comparison with other simple non-invasive indices for predicting liver fibrosis in HBV-infected patients.

Authors:  Beom Kyung Kim; Kwang Hyub Han; Jun Yong Park; Sang Hoon Ahn; Chae Yoon Chon; Ja Kyung Kim; Yong Han Paik; Kwan Sik Lee; Young Nyun Park; Do Young Kim
Journal:  Dig Dis Sci       Date:  2009-12-04       Impact factor: 3.199

7.  Prevalence of cirrhosis in hepatitis C patients in the Chronic Hepatitis Cohort Study (CHeCS): a retrospective and prospective observational study.

Authors:  Stuart C Gordon; Lois E Lamerato; Loralee B Rupp; Scott D Holmberg; Anne C Moorman; Philip R Spradling; Eyasu Teshale; Fujie Xu; Joseph A Boscarino; Vinutha Vijayadeva; Mark A Schmidt; Nancy Oja-Tebbe; Mei Lu
Journal:  Am J Gastroenterol       Date:  2015-07-28       Impact factor: 10.864

Review 8.  Noninvasive models for assessment of liver fibrosis in patients with chronic hepatitis B virus infection.

Authors:  Da-Wu Zeng; Jing Dong; Yu-Rui Liu; Jia-Ji Jiang; Yue-Yong Zhu
Journal:  World J Gastroenterol       Date:  2016-08-07       Impact factor: 5.742

9.  FibroScan, aspartate aminotransferase and alanine aminotransferase ratio (AAR), aspartate aminotransferase to platelet ratio index (APRI), fibrosis index based on the 4 factor (FIB-4), and their combinations in the assessment of liver fibrosis in patients with hepatitis B.

Authors:  Deping Ding; Hongbing Li; Ping Liu; Lingli Chen; Jian Kang; Yinhua Zhang; Deqiang Ma; Yue Chen; Jie Luo; Zhongji Meng
Journal:  Int J Clin Exp Med       Date:  2015-11-15

10.  Effects of Angiotensin Converting Enzyme Inhibitors on Liver Fibrosis in HIV and Hepatitis C Coinfection.

Authors:  Lindsey J Reese; Diane S Tider; Alicia C Stivala; Dawn A Fishbein
Journal:  AIDS Res Treat       Date:  2012-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.